261 related articles for article (PubMed ID: 25688926)
1. Contrasting effects of fresh and fermented kimchi consumption on gut microbiota composition and gene expression related to metabolic syndrome in obese Korean women.
Han K; Bose S; Wang JH; Kim BS; Kim MJ; Kim EJ; Kim H
Mol Nutr Food Res; 2015 May; 59(5):1004-8. PubMed ID: 25688926
[TBL] [Abstract][Full Text] [Related]
2. Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients.
Kim EK; An SY; Lee MS; Kim TH; Lee HK; Hwang WS; Choe SJ; Kim TY; Han SJ; Kim HJ; Kim DJ; Lee KW
Nutr Res; 2011 Jun; 31(6):436-43. PubMed ID: 21745625
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of fresh and fermented kimchi in prediabetic individuals.
An SY; Lee MS; Jeon JY; Ha ES; Kim TH; Yoon JY; Ok CO; Lee HK; Hwang WS; Choe SJ; Han SJ; Kim HJ; Kim DJ; Lee KW
Ann Nutr Metab; 2013; 63(1-2):111-9. PubMed ID: 23969321
[TBL] [Abstract][Full Text] [Related]
4. Obesity, metabolic syndrome, and microbiota: multiple interactions.
Tilg H
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model.
Park S; Ji Y; Jung HY; Park H; Kang J; Choi SH; Shin H; Hyun CK; Kim KT; Holzapfel WH
Appl Microbiol Biotechnol; 2017 Feb; 101(4):1605-1614. PubMed ID: 27858139
[TBL] [Abstract][Full Text] [Related]
6. Rehmannia glutinosa reduced waist circumferences of Korean obese women possibly through modulation of gut microbiota.
Han K; Bose S; Kim YM; Chin YW; Kim BS; Wang JH; Lee JH; Kim H
Food Funct; 2015 Aug; 6(8):2684-92. PubMed ID: 26139477
[TBL] [Abstract][Full Text] [Related]
7. Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients.
Moreno-Indias I; Sánchez-Alcoholado L; Pérez-Martínez P; Andrés-Lacueva C; Cardona F; Tinahones F; Queipo-Ortuño MI
Food Funct; 2016 Apr; 7(4):1775-87. PubMed ID: 26599039
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects.
Aguirre M; Jonkers DM; Troost FJ; Roeselers G; Venema K
PLoS One; 2014; 9(11):e113864. PubMed ID: 25426858
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota and obesity.
Blaut M; Klaus S
Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota, diet, and obesity-related disorders-The good, the bad, and the future challenges.
Portune KJ; Benítez-Páez A; Del Pulgar EM; Cerrudo V; Sanz Y
Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27287778
[TBL] [Abstract][Full Text] [Related]
11. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
12. Microbiota and diabetes: an evolving relationship.
Tilg H; Moschen AR
Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
[TBL] [Abstract][Full Text] [Related]
13. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
[TBL] [Abstract][Full Text] [Related]
14. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome and metabolic syndrome.
Mazidi M; Rezaie P; Kengne AP; Mobarhan MG; Ferns GA
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S150-7. PubMed ID: 26916014
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiota, obesity and insulin resistance.
Shen J; Obin MS; Zhao L
Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
[TBL] [Abstract][Full Text] [Related]
17. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
[TBL] [Abstract][Full Text] [Related]
18. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
[TBL] [Abstract][Full Text] [Related]
19. The crosstalk between gut microbiota and obesity and related metabolic disorders.
Xu WT; Nie YZ; Yang Z; Lu NH
Future Microbiol; 2016 Jun; 11():825-36. PubMed ID: 27192213
[TBL] [Abstract][Full Text] [Related]
20. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
